
Vertex Announces Advancements of Suzetrigine (VX-548) in Acute and Neuropathic Pain
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) has unveiled significant progress in its suzetrigine pain program, potentially introducing the first new class of medication for acute and neuropathic pain in over twenty…













